ArticleBiomolecules2019

Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients.

Inga Zerr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.